129 related articles for article (PubMed ID: 11112350)
1. Human uroporphyrinogen-III synthase: genomic organization, alternative promoters, and erythroid-specific expression.
Aizencang G; Solis C; Bishop DF; Warner C; Desnick RJ
Genomics; 2000 Dec; 70(2):223-31. PubMed ID: 11112350
[TBL] [Abstract][Full Text] [Related]
2. Uroporphyrinogen III synthase. An alternative promoter controls erythroid-specific expression in the murine gene.
Aizencang GI; Bishop DF; Forrest D; Astrin KH; Desnick RJ
J Biol Chem; 2000 Jan; 275(4):2295-304. PubMed ID: 10644678
[TBL] [Abstract][Full Text] [Related]
3. Congenital erythropoietic porphyria: prolonged high-level expression and correction of the heme biosynthetic defect by retroviral-mediated gene transfer into porphyric and erythroid cells.
Kauppinen R; Glass IA; Aizencang G; Astrin KH; Atweh GF; Desnick RJ
Mol Genet Metab; 1998 Sep; 65(1):10-7. PubMed ID: 9787090
[TBL] [Abstract][Full Text] [Related]
4. Uroporphyrinogen III synthase erythroid promoter mutations in adjacent GATA1 and CP2 elements cause congenital erythropoietic porphyria.
Solis C; Aizencang GI; Astrin KH; Bishop DF; Desnick RJ
J Clin Invest; 2001 Mar; 107(6):753-62. PubMed ID: 11254675
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia decreases the expression of the two enzymes responsible for producing linear and cyclic tetrapyrroles in the heme biosynthetic pathway.
Vargas PD; Furuyama K; Sassa S; Shibahara S
FEBS J; 2008 Dec; 275(23):5947-59. PubMed ID: 19021769
[TBL] [Abstract][Full Text] [Related]
6. Expression of alternative transcripts of ferroportin-1 during human erythroid differentiation.
Cianetti L; Segnalini P; Calzolari A; Morsilli O; Felicetti F; Ramoni C; Gabbianelli M; Testa U; Sposi NM
Haematologica; 2005 Dec; 90(12):1595-606. PubMed ID: 16330432
[TBL] [Abstract][Full Text] [Related]
7. Hydroxymethylbilane synthase: complete genomic sequence and amplifiable polymorphisms in the human gene.
Yoo HW; Warner CA; Chen CH; Desnick RJ
Genomics; 1993 Jan; 15(1):21-9. PubMed ID: 7916736
[TBL] [Abstract][Full Text] [Related]
8. Human uroporphyrinogen III synthase: NMR-based mapping of the active site.
Cunha L; Kuti M; Bishop DF; Mezei M; Zeng L; Zhou MM; Desnick RJ
Proteins; 2008 May; 71(2):855-73. PubMed ID: 18004775
[TBL] [Abstract][Full Text] [Related]
9. Cloning and functional characterization of the rat alpha2B-adrenergic receptor gene promoter region: Evidence for binding sites for erythropoiesis-related transcription factors GATA1 and NF-E2.
Schaak S; Cussac D; Labialle S; Mignotte V; Paris H
Biochem Pharmacol; 2005 Aug; 70(4):606-17. PubMed ID: 15993847
[TBL] [Abstract][Full Text] [Related]
10. Genomic organization of human arylamine N-acetyltransferase Type I reveals alternative promoters that generate different 5'-UTR splice variants with altered translational activities.
Butcher NJ; Arulpragasam A; Goh HL; Davey T; Minchin RF
Biochem J; 2005 Apr; 387(Pt 1):119-27. PubMed ID: 15487985
[TBL] [Abstract][Full Text] [Related]
11. GATA-1 binding sites in exon 1 direct erythroid-specific transcription of PPOX.
de Vooght KM; van Wijk R; van Solinge WW
Gene; 2008 Feb; 409(1-2):83-91. PubMed ID: 18191920
[TBL] [Abstract][Full Text] [Related]
12. Alternative promoter usage and alternative splicing contribute to mRNA heterogeneity of mouse monocarboxylate transporter 2.
Zhang SX; Searcy TR; Wu Y; Gozal D; Wang Y
Physiol Genomics; 2007 Dec; 32(1):95-104. PubMed ID: 17911380
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of the Arabidopsis gene encoding the tetrapyrrole biosynthesis enzyme uroporphyrinogen III synthase.
Tan FC; Cheng Q; Saha K; Heinemann IU; Jahn M; Jahn D; Smith AG
Biochem J; 2008 Mar; 410(2):291-9. PubMed ID: 18042043
[TBL] [Abstract][Full Text] [Related]
14. Genomic organization and promoter analysis of the mouse ADP-ribosylarginine hydrolase gene.
Aoki K; Kato J; Shoemaker MT; Moss J
Gene; 2005 May; 351():83-95. PubMed ID: 15893437
[TBL] [Abstract][Full Text] [Related]
15. GATA-1 and NF-Y cooperate to mediate erythroid-specific transcription of Gfi-1B gene.
Huang DY; Kuo YY; Lai JS; Suzuki Y; Sugano S; Chang ZF
Nucleic Acids Res; 2004; 32(13):3935-46. PubMed ID: 15280509
[TBL] [Abstract][Full Text] [Related]
16. Expression of adducin genes during erythropoiesis: a novel erythroid promoter for ADD2.
Yenerel MN; Sundell IB; Weese J; Bulger M; Gilligan DM
Exp Hematol; 2005 Jul; 33(7):758-66. PubMed ID: 15963851
[TBL] [Abstract][Full Text] [Related]
17. Two brothers with mild congenital erythropoietic porphyria due to a novel genotype.
Berry AA; Desnick RJ; Astrin KH; Shabbeer J; Lucky AW; Lim HW
Arch Dermatol; 2005 Dec; 141(12):1575-9. PubMed ID: 16365260
[TBL] [Abstract][Full Text] [Related]
18. A novel BDNF gene promoter directs expression to skeletal muscle.
Heinrich G
BMC Neurosci; 2003 Jun; 4():11. PubMed ID: 12812528
[TBL] [Abstract][Full Text] [Related]
19. Heme-dependent up-regulation of the alpha-globin gene expression by transcriptional repressor Bach1 in erythroid cells.
Tahara T; Sun J; Igarashi K; Taketani S
Biochem Biophys Res Commun; 2004 Nov; 324(1):77-85. PubMed ID: 15464985
[TBL] [Abstract][Full Text] [Related]
20. Structural organization of the human complexin 2 gene (CPLX2) and aspects of its functional activity.
Raevskaya NM; Dergunova LV; Vladychenskaya IP; Stavchansky VV; Oborina MV; Poltaraus AB; Limborska SA
Gene; 2005 Oct; 359():127-37. PubMed ID: 16162394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
